

(ShareCast News) - Shares in Summit Therapeutics surged after the company said that its phase 1B clinical trial of SMT C1100 for the treatment of Duch...


Drug discovery and development company Summit Therapeutics has received approval from the US and Food Drug Administration (FDA) for its novel antibiot...


Drug discovery and development company Summit Therapeutics posted a 52.6% widening in its first-quarter pre-tax loss, pointing to the cost of listing ...